# Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer

> **NCT06535893** · PHASE2 · RECRUITING · sponsor: **Nagoya City University** · enrollment: 100 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** TN
- **DRUG:** TN-1

## Key facts

- **NCT ID:** NCT06535893
- **Lead sponsor:** Nagoya City University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-30
- **Primary completion:** 2027-06-30
- **Final completion:** 2040-06-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06535893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06535893, "Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06535893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*